Nikolai Strusberg, MD, discussed how proton therapy and thyroid dose affect clinical hypothyroidism risk after supraclavicular breast radiation.
|Slideshows|November 16, 2016
Top Breast Cancer News of 2016
Author(s)Cancer Network Editors
This slide show highlights some of the top breast cancer news of 2016, including a study looking at optimal margins in DCIS, a trial on biosimilars, a new FDA approval, and more.
Advertisement
Advertisement
Related to this article
Data from the phase 3 HER2CLIMB-05 study support the FDA approval of tucatinib-based maintenance treatment in HER2-positive metastatic breast cancer.
Advertisement
Advertisement
Trending on CancerNetwork
1
VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors
2
Operationalizing the First Dose and Building the Oncology and Eye Care Partnership
3
Reading a Changed Eye Examination and Impact on Therapy
4
Personalized Cancer Vaccine Combo Is Feasible in Platinum-Sensitive Ovarian Cancer
5